Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mukesh C Joshi

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
European Journal of Medicinal Chemistry|December 14, 2024
Synthesis and mechanistic studies of 4-aminoquinoline-Isatin molecular hybrids and Schiff's bases as promising antimicrobial agentsMohd Shakir, Asghar Ali, Swati Lakshmi, et al.
Journal of Biomolecular Structure & Dynamics|January 27, 2026
Structure-based virtual screening and experimental validation of a MARK4 inhibitor for targeted cancer therapySarfraz Ahmed, Mohd Shakir, Haider Thaer Abdulhameed Almuqdadi, et al.
Heliyon|February 8, 2024
Biological evaluation of novel side chain containing CQTrICh-analogs as antimalarials and their development as <i>Pf</i>CDPK1 kinase inhibitorsIram Irfan, Amad Uddin, Ravi Jain, et al.
ACS Omega|November 1, 2021
Development of Oxadiazole-Sulfonamide-Based Compounds as Potential Antibacterial AgentsAsghar Ali, Phool Hasan, Mohammad Irfan, et al.
European Journal of Medicinal Chemistry|December 1, 2023
Blood-stage antimalarial activity, favourable metabolic stability and in vivo toxicity of novel piperazine linked 7-chloroquinoline-triazole conjugatesAmad Uddin, Sonal Gupta, Rumaisha Shoaib, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
European Journal of Medicinal Chemistry|December 14, 2024
Synthesis and mechanistic studies of 4-aminoquinoline-Isatin molecular hybrids and Schiff's bases as promising antimicrobial agentsMohd Shakir, Asghar Ali, Swati Lakshmi, et al.
Journal of Biomolecular Structure & Dynamics|January 27, 2026
Structure-based virtual screening and experimental validation of a MARK4 inhibitor for targeted cancer therapySarfraz Ahmed, Mohd Shakir, Haider Thaer Abdulhameed Almuqdadi, et al.
Heliyon|February 8, 2024
Biological evaluation of novel side chain containing CQTrICh-analogs as antimalarials and their development as <i>Pf</i>CDPK1 kinase inhibitorsIram Irfan, Amad Uddin, Ravi Jain, et al.
ACS Omega|November 1, 2021
Development of Oxadiazole-Sulfonamide-Based Compounds as Potential Antibacterial AgentsAsghar Ali, Phool Hasan, Mohammad Irfan, et al.
European Journal of Medicinal Chemistry|December 1, 2023
Blood-stage antimalarial activity, favourable metabolic stability and in vivo toxicity of novel piperazine linked 7-chloroquinoline-triazole conjugatesAmad Uddin, Sonal Gupta, Rumaisha Shoaib, et al.
Pageof 2